The Riverside Company Invests in HemaTerra Technologies

The Riverside Company Invests in Champion Healthcare Technologies and Combines It with HemaTerra

June 6, 2019

Cloud & SaaS

The Riverside Company has invested in Champion Healthcare Technologies and combined it with HemaTerra Technologies (a company Riverside invested in earlier) to form a leading medical specialty software business. The combined firm will provide SaaS solutions for implant lifecycle management and blood/plasma collection operations, serving over 500 hospitals and numerous independent blood and plasma centers across the United States.

InVita Healthcare Technologies / The Riverside Company Acquire BloodHub

October 6, 2022

Cloud & SaaS

InVita Healthcare Technologies, a portfolio company of The Riverside Company, has acquired BloodHub and folded it into InVita's Blood Management Division. Riverside made the investment as an add-on to its InVita platform to expand InVita's blood- and biologics-focused supply chain and laboratory software capabilities across North America.

Edgewater Capital Partners Acquires Haematologic Technologies

October 11, 2019

Biotechnology

Edgewater Capital Partners has entered into an agreement to acquire Haematologic Technologies Incorporated, a Vermont-based provider of biologic products, reagents and GMP-compliant assay development and testing services for the biopharmaceutical industry. Edgewater said it will support HTI's next phase of growth and build the company as a premier outsourced services partner for biologics; financial terms were not disclosed.

The Riverside Company Invests in Alpha-H

April 30, 2019

Consumer Products

The Riverside Company has invested in Alpha-H, the Australian skincare maker best known for its Liquid Gold exfoliating treatment, to support the brand's international growth and product development. Riverside will partner with Alpha-H's existing management and shareholders to accelerate distribution across new and existing regions; KPMG M&A advised Alpha-H and Riverside was advised by KPMG, Deloitte and Herbert Smith Freehills.

Riverside Adds Transplant Connect to InVita Healthcare Technologies Platform

January 18, 2022

Healthcare Services

The Riverside Company has invested in Transplant Connect, maker of the iTransplant software platform, as an add-on to Riverside’s healthcare software platform InVita Healthcare Technologies. Transplant Connect, founded in 2003 and based in Los Angeles, provides clinical information management, communications, analytics and logistics across the lifecycle of human biologic donation and transplantation.

The Riverside Company Acquires HealthTech BioActives (HTBA) from Ferrer

December 13, 2019

Pharmaceuticals

The Riverside Company has acquired HealthTech BioActives S.L. (HTBA), a Spanish manufacturer of APIs, excipients, natural flavors and vitamin B12 derivatives, in a carve-out from Ferrer. Riverside will work with HTBA’s ~140 employees and its manufacturing sites in Beniel (Murcia) and Barcelona to strengthen commercial capabilities, accelerate new product development and expand global sales.